Geneticist Announces Congressional Bid

UC Berkeley researcher Michael Eisen says he will run for Senate in 2018.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, PLOSGeneticist Michael Eisen of the University of California, Berkeley, has been a vocal opponent of Donald Trump. Now, the researcher has announced his intent to run for US Senate. “We can't sit around and hope other people are going to solve our problems for us - time to step up, if you can…,” Eisen posted on his Twitter account on Sunday (January 29) after announcing his senate run last week (January 25).

“Too much of the scientific establishment looks at the government as a bank—that the primary thing we should worry about is can we get the right amount of money out of Congress,” Eisen told Science. “Too few people focus on the fact that science needs to be a partnership with the public for it to thrive.”

Eisen, who told Science that he plans to run as an independent, is perhaps the most recognizable name in a list of other scientists who are considering running for office to combat policies that seem broadly antagonistic to science. The groundswell is partly thanks to 314 Action, an organization run by chemist and former breast cancer researcher Shaughnessy Naughton, who ran for Congress in 2014 and 2016 but lost ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo